Asthma and chronic obstructive pulmonary disease (COPD) are two of the most common chronic respiratory diseases. Electronic medical records (EMRs) are increasingly being used as a means to support chronic disease management and enable best practices. This article summarizes the state of asthma and COPD care and electronic solutions in Ontario, highlighting the work done to date for asthma and COPD data standards. Lessons learned and future considerations for the use of EMRs and related electronic solutions to support chronic disease management are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12927/hcq.2020.26271 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Contemporary Approach to the Treatment of Perioperative Bronchospasm.
Transl Perioper Pain Med
February 2020
Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, California, USA.
The incidence of asthma is increasing, and the ageing of the United States population is leading to an increase in the prevalence of patients living with chronic obstructive pulmonary disease. This has led to an increased need to manage bronchospasm in the perioperative period. Very effective methods to treat bronchospasm like intravenous dexmedetomidine, lidocaine, magnesium, ketamine and steroids as well as inhalational sevoflurane are available but are currently underused.
View Article and Find Full Text PDFFactors affecting poor prognosis of COVID-19 in people living with human immunodeficiency virus: A systematic review and meta-analysis of co-infection.
Int J Health Sci (Qassim)
January 2025
Department of Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Objectives: This study aims to assess the correlation between clinical features and mortality in human immunodeficiency virus (HIV)-infected individuals with COVID-19.
Methods: A systematic literature search was conducted for cohort, cross-sectional, and case series that reported co-infection with HIV and COVID-19 published from January to September 2020. Clinical features such as age, comorbidities, CD4T lymphocyte counts, HIV RNA levels, and antiretroviral regimens were evaluated using meta-analyses and systematic reviews.
Comparison of Smoking Cessation Outcomes in Smokers With Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Asthma, and Healthy Smokers: A Prospective Study of 400 Participants.
Cureus
December 2024
Chest Diseases, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, TUR.
Objectives: In this study, we aimed to demonstrate the effect of motivational interviewing with a specific cohort of smokers on smoking cessation. Furthermore, we investigated the influence of medical conditions and individual traits on the efficacy of motivational interviewing for smoking cessation.
Methods: This prospective study was conducted with smokers who presented at the pulmonology and cardiology outpatient clinic.
Association between asthma and cardiovascular disease: evidence from the national health and nutrition examination survey 1999-2018.
Front Cardiovasc Med
December 2024
Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China.
Background: Cardiovascular disease(CVD) remains a significant global challenge. Asthma, which is characterized by airway hyperresponsiveness and reversible and limited airflow, plays an important role in cardiovascular diseases. This study aimed to investigate the association between asthma and CVD.
View Article and Find Full Text PDFNatural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases.
Front Pharmacol
December 2024
Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Pulmonary diseases are a major category of diseases that pose a threat to human health. The most common drugs currently used to treat lung diseases are still chemical drugs, but this may lead to drug resistance and damage to healthy organs in the body. Therefore, developing new drugs is an urgent task.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!